{"id":13561,"date":"2024-10-23T17:15:53","date_gmt":"2024-10-23T14:15:53","guid":{"rendered":"https:\/\/ozgurkilickesmez.com\/?p=13561"},"modified":"2025-12-12T14:55:08","modified_gmt":"2025-12-12T11:55:08","slug":"carcinom-tiroidian-papilar","status":"publish","type":"post","link":"https:\/\/ozgurkilickesmez.com\/ro\/carcinom-tiroidian-papilar\/","title":{"rendered":"Carcinom Tiroidian Papilar"},"content":{"rendered":"<p>Cancerul tiroidian papilar este cel mai frecvent tip de cancer al tiroidei. Are o evolu\u021bie lent\u0103 \u0219i se poate r\u0103sp\u00e2ndi la ganglionii limfatici. \u00cen stadii incipiente, rata de supravie\u021buire este ridicat\u0103 cu tratament chirurgical \u0219i iod radioactiv.<\/p>\n<p>Printre factorii de risc ai cancerului tiroidian papilar se num\u0103r\u0103 expunerea la radia\u021bii, muta\u021biile genetice \u0219i antecedentele familiale. Este mai frecvent la femei. Pentru diagnostic se utilizeaz\u0103 ecografia \u0219i biopsia cu ac fin.<\/p>\n<p>\u00cen tratamentul cancerului tiroidian papilar se aplic\u0103 tiroidectomia total\u0103. Dac\u0103 este necesar, se adaug\u0103 terapia cu iod radioactiv \u0219i tratamentul de suprimare a TSH. Aceste metode reduc riscul de recidiv\u0103.<\/p>\n<p>\u00cen urm\u0103rirea cancerului tiroidian papilar se m\u0103soar\u0103 nivelul de tiroglobulin\u0103, se efectueaz\u0103 ecografii cervicale regulate \u0219i teste hormonale. Prognosticul este foarte bun dac\u0103 este diagnosticat precoce.<\/p>\n<table>\n<tbody>\n<tr>\n<td>Denumirea bolii<\/td>\n<td>Cancer Tiroidian Papilar<\/td>\n<\/tr>\n<tr>\n<td>Defini\u021bie<\/td>\n<td>Cancerul tiroidian papilar, cel mai frecvent tip de cancer tiroidian, progreseaz\u0103 de obicei lent \u0219i tinde s\u0103 se r\u0103sp\u00e2ndeasc\u0103 la ganglionii limfatici.<\/td>\n<\/tr>\n<tr>\n<td>Simptome<\/td>\n<td>Umfl\u0103tur\u0103 sau nodul nedureros la nivelul g\u00e2tului, dificult\u0103\u021bi la \u00eenghi\u021bire sau respira\u021bie, r\u0103gu\u0219eal\u0103, uneori m\u0103rirea ganglionilor limfatici cervicali.<\/td>\n<\/tr>\n<tr>\n<td>Cauze<\/td>\n<td>Muta\u021bii genetice (muta\u021bii RET\/PTC \u0219i BRAF), expunere la radia\u021bii, predispozi\u021bie familial\u0103; \u00een unele cazuri apare f\u0103r\u0103 o cauz\u0103 clar\u0103.<\/td>\n<\/tr>\n<tr>\n<td>Factori de risc<\/td>\n<td>Sex feminin, v\u00e2rsta \u00eentre 30-50 ani, antecedente familiale de cancer tiroidian, expunere la radia\u021bii (mai ales \u00een copil\u0103rie).<\/td>\n<\/tr>\n<tr>\n<td>Metode de diagnostic<\/td>\n<td>Examen fizic, ecografie tiroidian\u0103, biopsie prin aspira\u021bie cu ac fin (pentru confirmarea diagnosticului), teste hormonale TSH, T3 \u0219i T4, tehnici imagistice precum CT sau RMN.<\/td>\n<\/tr>\n<tr>\n<td>Metode de tratament<\/td>\n<td>Tiroidectomie total\u0103 sau subtotal\u0103 (\u00eendep\u0103rtarea complet\u0103 sau par\u021bial\u0103 a tiroidei), terapie cu iod radioactiv (pentru distrugerea celulelor r\u0103mase), terapie de substitu\u021bie hormonal\u0103 (pentru compensarea deficitului de hormoni tiroidieni).<\/p>\n<p>La tumorile sub 2 cm, abla\u021bia poate fi aplicat\u0103 cu succes.<\/td>\n<\/tr>\n<tr>\n<td>Prognostic<\/td>\n<td>Prognosticul este de obicei foarte bun cu diagnostic \u0219i tratament precoce; deoarece cancerul tiroidian papilar are o tendin\u021b\u0103 de cre\u0219tere lent\u0103, are un impact minim asupra duratei de via\u021b\u0103.<\/td>\n<\/tr>\n<tr>\n<td>Monitorizare \u0219i urm\u0103rire<\/td>\n<td>Dup\u0103 tratament se m\u0103soar\u0103 tiroglobulina (pentru detectarea recidivei), se efectueaz\u0103 ecografii cervicale regulate \u0219i, la nevoie, scan\u0103ri cu iod radioactiv.<\/td>\n<\/tr>\n<tr>\n<td>Complica\u021bii<\/td>\n<td>Hipotiroidism dup\u0103 interven\u021bia chirurgical\u0103 (\u00een caz de \u00eendep\u0103rtare total\u0103 a tiroidei), r\u0103gu\u0219eal\u0103, rar r\u0103sp\u00e2ndirea bolii la ganglioni sau organe \u00eendep\u0103rtate.<\/td>\n<\/tr>\n<tr>\n<td>Metode de preven\u021bie<\/td>\n<td>Nu exist\u0103 o metod\u0103 clar\u0103 de prevenire, \u00eens\u0103 pentru persoanele cu risc crescut sunt importante controalele tiroidiene regulate \u0219i protec\u021bia fa\u021b\u0103 de radia\u021bii.<\/td>\n<\/tr>\n<tr>\n<td>R\u0103spuns la tratament<\/td>\n<td>R\u0103spunsul la tratament este de obicei bun; riscul de recidiv\u0103 este redus, iar recidiva poate fi detectat\u0103 precoce prin monitorizarea nivelurilor sc\u0103zute de tiroglobulin\u0103.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\t<section class=\"section\" id=\"section_1638493369\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n\n<div class=\"row\"  id=\"row-1647507474\">\n\n\n\t<div id=\"col-240216940\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\" style=\"background-color:#1c58ef;\" >\n\t\t\t\n\t\t\t\n\n<div class=\"row\"  id=\"row-1771772553\">\n\n\n\t<div id=\"col-1783273287\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n\t<div class=\"img has-hover border-gorsel x md-x lg-x y md-y lg-y\" id=\"image_753743514\">\n\t\t\t\t\t\t\t\t<div class=\"img-inner dark\" >\n\t\t\t<img decoding=\"async\" width=\"1020\" height=\"1020\" src=\"https:\/\/ozgurkilickesmez.com\/wp-content\/uploads\/2025\/08\/Medic-specialist-in-Radiologie-Interventionala-si-Neuroradiologie-1024x1024.webp\" class=\"attachment-large size-large\" alt=\"Medic specialist \u00een Radiologie Interven\u021bional\u0103 \u0219i Neuroradiologie\" srcset=\"https:\/\/ozgurkilickesmez.com\/wp-content\/uploads\/2025\/08\/Medic-specialist-in-Radiologie-Interventionala-si-Neuroradiologie-1024x1024.webp 1024w, https:\/\/ozgurkilickesmez.com\/wp-content\/uploads\/2025\/08\/Medic-specialist-in-Radiologie-Interventionala-si-Neuroradiologie-300x300.webp 300w, https:\/\/ozgurkilickesmez.com\/wp-content\/uploads\/2025\/08\/Medic-specialist-in-Radiologie-Interventionala-si-Neuroradiologie-150x150.webp 150w, https:\/\/ozgurkilickesmez.com\/wp-content\/uploads\/2025\/08\/Medic-specialist-in-Radiologie-Interventionala-si-Neuroradiologie.webp 1080w\" sizes=\"(max-width: 1020px) 100vw, 1020px\" title=\"\">\t\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\n<style>\n#image_753743514 {\n  width: 100%;\n}\n<\/style>\n\t<\/div>\n\t\n\n\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1783273287 > .col-inner {\n  border-radius: 20px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1595468439\" class=\"col medium-8 small-12 large-8\"  >\n\t\t\t\t<div class=\"col-inner dark\"  >\n\t\t\t\n\t\t\t\n\n\t<div id=\"text-791198770\" class=\"text\">\n\t\t\n\n<p><strong>Prof. Dr. \u00d6zg\u00fcr KILI\u00c7KESMEZ<br \/><\/strong><span style=\"font-size: 65%;\"><em>Radiologie Interven\u021bional\u0103 \/ Neuroradiologie Interven\u021bional\u0103<\/em><\/span><\/p>\n\t\t\n<style>\n#text-791198770 {\n  font-size: 1.25rem;\n}\n@media (min-width:550px) {\n  #text-791198770 {\n    font-size: 2rem;\n  }\n}\n<\/style>\n\t<\/div>\n\t\n<p>Prof. Dr. K\u0131l\u0131\u00e7kesmez de\u021bine Certificatul de Competen\u021b\u0103 \u00een Radiologie din Turcia, Certificatul de Competen\u021b\u0103 \u00een Radiologie Interven\u021bional\u0103 din Turcia, Certificarea pentru tratamentul accidentului vascular cerebral \u0219i Certificatul European de Radiologie Interven\u021bional\u0103 (EBIR). \u00cen cariera sa academic\u0103, a c\u00e2\u0219tigat Premiul I Siemens pentru Radiologie \u00een 2008.<\/p>\n\n<a href=\"https:\/\/ozgurkilickesmez.com\/kimdir\/\" class=\"button white lowercase hide-for-small\" style=\"border-radius:15px;\">\n\t\t<span>CV<\/span>\n\t<\/a>\n\n\n<a href=\"https:\/\/ozgurkilickesmez.com\/kimdir\/oduller\/\" class=\"button white lowercase hide-for-small\" style=\"border-radius:15px;\">\n\t\t<span>Premii<\/span>\n\t<\/a>\n\n\n<a href=\"https:\/\/www.google.com\/search?sa=X&#038;sca_esv=02ef9b5328b381af&#038;tbm=lcl&#038;q=Prof+%C3%96zg%C3%BCr+K%C4%B1l%C4%B1%C3%A7kesmez+Recenzii&#038;rflfq=1&#038;num=20\" class=\"button white lowercase hide-for-small\" style=\"border-radius:15px;\" target=\"_blank\" rel=\"noopener\">\n\t\t<span>Recenzii<\/span>\n\t<\/a>\n\n\n<div class=\"row show-for-small\"  id=\"row-1461287768\">\n\n\n\t<div id=\"col-1842741450\" class=\"col medium-6 small-6 large-6\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n<a href=\"https:\/\/ozgurkilickesmez.com\/kimdir\/\" class=\"button white lowercase expand\" style=\"border-radius:15px;\">\n\t\t<span>CV<\/span>\n\t<\/a>\n\n\n<a href=\"https:\/\/ozgurkilickesmez.com\/kimdir\/akademik-makaleler\/\" class=\"button white lowercase expand\" style=\"border-radius:15px;\">\n\t\t<span>Articole<\/span>\n\t<\/a>\n\n\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n\t<div id=\"col-1729240707\" class=\"col medium-6 small-6 large-6\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n<a href=\"https:\/\/ozgurkilickesmez.com\/kimdir\/oduller\/\" class=\"button white lowercase expand\" style=\"border-radius:15px;\">\n\t\t<span>Premii<\/span>\n\t<\/a>\n\n\n<a href=\"https:\/\/www.google.com\/search?sa=X&#038;sca_esv=02ef9b5328b381af&#038;tbm=lcl&#038;q=Prof+%C3%96zg%C3%BCr+K%C4%B1l%C4%B1%C3%A7kesmez+Recenzii&#038;rflfq=1&#038;num=20\" class=\"button white lowercase expand\" style=\"border-radius:15px;\" target=\"_blank\" rel=\"noopener\">\n\t\t<span>Recenzii<\/span>\n\t<\/a>\n\n\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n\n<\/div>\n\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1595468439 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n@media (min-width:550px) {\n  #col-1595468439 > .col-inner {\n    margin: 0px 0px 0px 0px;\n  }\n}\n<\/style>\n\t<\/div>\n\n\t\n\n<\/div>\n\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-240216940 > .col-inner {\n  padding: 30px 30px 1px 30px;\n  border-radius: 20px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n<\/div>\n\n\t\t<\/div>\n\n\t\t\n<style>\n#section_1638493369 {\n  padding-top: 30px;\n  padding-bottom: 30px;\n}\n<\/style>\n\t<\/section>\n\t\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_89 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Con\u021binutul articolului<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #ffffff;color:#ffffff\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #ffffff;color:#ffffff\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/carcinom-tiroidian-papilar\/#Ce_Este_Cancerul_Tiroidian_Papilar\" >Ce Este Cancerul Tiroidian Papilar?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/carcinom-tiroidian-papilar\/#Care_Sunt_Cauzele_Cancerului_Tiroidian_Papilar\" >Care Sunt Cauzele Cancerului Tiroidian Papilar?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/carcinom-tiroidian-papilar\/#Cat_de_Frecvent_Este_Cancerul_Tiroidian_Papilar\" >C\u00e2t de Frecvent Este Cancerul Tiroidian Papilar?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/carcinom-tiroidian-papilar\/#Cum_Se_Dezvolta_Cancerul_Tiroidian_Papilar\" >Cum Se Dezvolt\u0103 Cancerul Tiroidian Papilar?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/carcinom-tiroidian-papilar\/#Care_Sunt_Simptomele_Cancerului_Tiroidian_Papilar\" >Care Sunt Simptomele Cancerului Tiroidian Papilar?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/carcinom-tiroidian-papilar\/#Cum_Se_Diagnostica_Cancerul_Tiroidian_Papilar\" >Cum Se Diagnostic\u0103 Cancerul Tiroidian Papilar?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/carcinom-tiroidian-papilar\/#Cum_Se_Trateaza_Cancerul_Tiroidian_Papilar\" >Cum Se Trateaz\u0103 Cancerul Tiroidian Papilar?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/carcinom-tiroidian-papilar\/#Care_Sunt_Factorii_de_Risc_ai_Cancerului_Tiroidian_Papilar\" >Care Sunt Factorii de Risc ai Cancerului Tiroidian Papilar?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/carcinom-tiroidian-papilar\/#Cand_Poate_Fi_Tratata_Cancerul_Tiroidian_Papilar\" >C\u00e2nd Poate Fi Tratat\u0103 Cancerul Tiroidian Papilar?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/carcinom-tiroidian-papilar\/#Cand_Nu_Poate_Fi_Aplicat_Tratamentul_Cancerului_Tiroidian_Papilar\" >C\u00e2nd Nu Poate Fi Aplicat Tratamentul Cancerului Tiroidian Papilar?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/carcinom-tiroidian-papilar\/#Care_Este_Procesul_de_Recuperare_Dupa_Tratamentul_Cancerului_Tiroidian_Papilar\" >Care Este Procesul de Recuperare Dup\u0103 Tratamentul Cancerului Tiroidian Papilar?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/carcinom-tiroidian-papilar\/#Cum_Poate_Fi_Prevenit_Cancerul_Tiroidian_Papilar\" >Cum Poate Fi Prevenit Cancerul Tiroidian Papilar?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/ozgurkilickesmez.com\/ro\/carcinom-tiroidian-papilar\/#Intrebari_Frecvente\" >\u00centreb\u0103ri Frecvente<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Ce_Este_Cancerul_Tiroidian_Papilar\"><\/span>Ce Este Cancerul Tiroidian Papilar?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p> Cancerul tiroidian papilar este cel mai frecvent tip de cancer tiroidian care provine din celulele foliculare ale glandei tiroide. Acest tip de cancer progreseaz\u0103 de obicei lent, iar celulele sunt diferen\u021biate asem\u0103n\u0103tor celor tiroidiene normale. Cu toate acestea, \u00een unele cazuri se poate r\u0103sp\u00e2ndi la ganglionii limfatici din apropiere. Muta\u021biile genei BRAF joac\u0103 un rol important \u00een dezvoltarea PTC, \u00een special muta\u021bia BRAFV600E este asociat\u0103 cu forme mai agresive. De asemenea, expunerea la radia\u021bii se num\u0103r\u0103 printre factorii de risc. Cancerul tiroidian papilar detectat \u00een stadii incipiente are un prognostic foarte bun, cu rate ridicate de supravie\u021buire. Totu\u0219i, \u00een cazurile avansate, boala poate avea un curs mai agresiv \u0219i tratamentul devine mai dificil. <\/p>\n<h2><span class=\"ez-toc-section\" id=\"Care_Sunt_Cauzele_Cancerului_Tiroidian_Papilar\"><\/span>Care Sunt Cauzele Cancerului Tiroidian Papilar?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p> Cauzele cancerului tiroidian papilar se concentreaz\u0103 pe muta\u021bii genetice \u0219i factori de mediu. Rearanj\u0103rile BRAF \u0219i RET\/PTC au un rol semnificativ \u00een mecanismele moleculare ale bolii. Muta\u021bia BRAF V600E este una dintre cele mai frecvente modific\u0103ri genetice din acest tip de cancer. Aceast\u0103 muta\u021bie determin\u0103 cre\u0219terea necontrolat\u0103 a celulelor, declan\u0219\u00e2nd dezvoltarea tumorii. Atunci c\u00e2nd se combin\u0103 cu alte muta\u021bii genetice, poate duce la forme mai agresive ale bolii.<\/p>\n<p>Rearanj\u0103rile RET\/PTC sunt specifice cancerului tiroidian papilar. Aceste modific\u0103ri genetice sunt mai frecvente la persoanele expuse la radia\u021bii ionizante. Expunerea la radia\u021bii \u00een copil\u0103rie constituie un risc mai mare, fiind cauzat\u0103 de tratamente medicale sau dezastre de mediu. Astfel de rearanj\u0103ri determin\u0103 o cre\u0219tere continu\u0103 a celulelor tumorale, acceler\u00e2nd dezvoltarea cancerului.<\/p>\n<p>Al\u021bi factori genetici au, de asemenea, un rol important \u00een apari\u021bia bolii. De exemplu, muta\u021biile promotorului TERT \u0219i modific\u0103rile genei RAS sunt asociate cu forme mai agresive \u0219i rezistente la tratament. Aceste muta\u021bii pot facilita progresia cancerului.<\/p>\n<p>Antecedentele familiale \u0219i sindroamele genetice sunt \u0219i ele factori de risc. Persoanele cu istoric familial de cancer tiroidian au un risc crescut, iar urm\u0103toarele sindroame genetice cresc riscul:<\/p>\n<ul>\n<li aria-level=\"1\">Polipoz\u0103 adenomatoas\u0103 familial\u0103 (FAP)<\/li>\n<li aria-level=\"1\">Sindromul Cowden<\/li>\n<\/ul>\n<p> Aceste sindroame sunt legate de muta\u021bii ale genelor care controleaz\u0103 cre\u0219terea celular\u0103. <\/p>\n<h2><span class=\"ez-toc-section\" id=\"Cat_de_Frecvent_Este_Cancerul_Tiroidian_Papilar\"><\/span>C\u00e2t de Frecvent Este Cancerul Tiroidian Papilar?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p> Cancerul tiroidian papilar este cel mai frecvent subtip al cancerului tiroidian, reprezent\u00e2nd majoritatea cazurilor. \u00cen ultimii ani s-a observat o cre\u0219tere semnificativ\u0103 a inciden\u021bei acestui tip de cancer. Una dintre cauzele acestei cre\u0219teri este dezvoltarea metodelor de diagnostic, care pot detecta mai u\u0219or tumorile mici. Astfel, multe tumori mici care anterior nu erau descoperite sunt acum diagnosticate.<\/p>\n<p>Aceast\u0103 situa\u021bie a crescut \u00eengrijor\u0103rile legate de supradiagnostic, mai ales \u00een \u021b\u0103rile dezvoltate. Studiile arat\u0103 c\u0103 multe dintre cazurile noi nu constituie o amenin\u021bare serioas\u0103 pentru s\u0103n\u0103tate. \u00cen regiunile economic dezvoltate, ratele de diagnostic sunt mai mari din aceast\u0103 cauz\u0103.<\/p>\n<p>Cancerul tiroidian papilar este mai frecvent la femei. Femeile au un risc de trei ori mai mare dec\u00e2t b\u0103rba\u021bii de a dezvolta aceast\u0103 boal\u0103. V\u00e2rsta este, de asemenea, un factor important, boala fiind cel mai des \u00eent\u00e2lnit\u0103 \u00eentre 30 \u0219i 50 de ani. Cu toate acestea, cancerul tiroidian papilar se poate dezvolta la orice v\u00e2rst\u0103.<\/p>\n<p>Din punct de vedere geografic, acest tip de cancer este cel mai frecvent \u00een \u021b\u0103rile cu venituri ridicate. America de Nord \u0219i anumite \u021b\u0103ri europene au cele mai mari rate, iar Coreea de Sud raporteaz\u0103, de asemenea, inciden\u021be ridicate datorit\u0103 programelor intense de screening. La nivel global, cancerul tiroidian papilar este unul dintre tipurile de cancer cu cea mai rapid\u0103 cre\u0219tere.<\/p>\n\n\t<section class=\"section\" id=\"section_1764528020\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\n\n<div class=\"row\"  id=\"row-1995995516\">\n\n\n\t<div id=\"col-627088743\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner box-shadow-2\"  >\n\t\t\t\n\t\t\t\n\n<div class=\"row\"  id=\"row-833612381\">\n\n\n\t<div id=\"col-1200187331\" class=\"col whatsapp-alani hide-for-small medium-3 small-12 large-3\"  >\n\t\t\t\t<div class=\"col-inner box-shadow-2\" style=\"background-color:rgb(37, 211, 102);\" >\n\t\t\t\n\t\t\t\n\n\t<div id=\"text-4010820491\" class=\"text\">\n\t\t\n\n<p><a href=\"https:\/\/api.whatsapp.com\/send\/?phone=905405032303&amp;text=Bun\u0103%2C+v\u0103+contactez+de+pe+https%3A%2F%2Fozgurkilickesmez.com%2F&amp;type=phone_number&amp;app_absent=0\"><span style=\"color: #ffffff;\">WhatsApp 24\/7 <br \/>Apas\u0103 <\/span><span style=\"color: #ffffff;\">Aici!<\/span><\/a><\/p>\n\t\t\n<style>\n#text-4010820491 {\n  font-size: 1.5rem;\n  text-align: center;\n  color: rgb(255,255,255);\n}\n#text-4010820491 > * {\n  color: rgb(255,255,255);\n}\n<\/style>\n\t<\/div>\n\t\n\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1200187331 > .col-inner {\n  padding: 30px 0px 12px 0px;\n  margin: 0px 0px -31px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-668950611\" class=\"col show-for-small medium-3 small-12 large-3\"  >\n\t\t\t\t<div class=\"col-inner box-shadow-2\" style=\"background-color:rgb(37, 211, 102);\" >\n\t\t\t\n\t\t\t\n\n\t<div id=\"text-2104148869\" class=\"text\">\n\t\t\n\n<p><span style=\"color: #ffffff;\"><a style=\"color: #ffffff;\" href=\"https:\/\/api.whatsapp.com\/send\/?phone=905405032303&amp;text=Bun\u0103%2C+v\u0103+contactez+de+pe+https%3A%2F%2Fozgurkilickesmez.com%2F&amp;type=phone_number&amp;app_absent=0\">Apas\u0103 aici pentru suport WhatsApp 24\/7!<\/a><\/span><\/p>\n\t\t\n<style>\n#text-2104148869 {\n  font-size: 1.25rem;\n  text-align: center;\n  color: rgb(255,255,255);\n}\n#text-2104148869 > * {\n  color: rgb(255,255,255);\n}\n@media (min-width:550px) {\n  #text-2104148869 {\n    font-size: 1.5rem;\n  }\n}\n<\/style>\n\t<\/div>\n\t\n\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-668950611 > .col-inner {\n  padding: 20px 0px 1px 0px;\n  margin: 0px 0px 0px 0px;\n  border-radius: 100px;\n}\n@media (min-width:550px) {\n  #col-668950611 > .col-inner {\n    margin: 0px 0px -40px 0px;\n  }\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1734373985\" class=\"col medium-9 small-12 large-9\"  >\n\t\t\t\t<div class=\"col-inner text-left\"  >\n\t\t\t\n\t<div class=\"is-border\"\n\t\tstyle=\"border-width:0px 0px 0px 0px;margin:0px 0px 0px 0px;\">\n\t<\/div>\n\t\t\t\n\n<div class=\"row\"  id=\"row-2063682082\">\n\n\n\t<div id=\"col-1761202747\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n\n<div class=\"wpcf7 no-js\" id=\"wpcf7-f8836-o1\" lang=\"tr-TR\" dir=\"ltr\" data-wpcf7-id=\"8836\">\n<div class=\"screen-reader-response\"><p role=\"status\" aria-live=\"polite\" aria-atomic=\"true\"><\/p> <ul><\/ul><\/div>\n<form action=\"\/ro\/wp-json\/wp\/v2\/posts\/13561#wpcf7-f8836-o1\" method=\"post\" class=\"wpcf7-form init\" aria-label=\"Contact form\" novalidate=\"novalidate\" data-status=\"init\">\n<fieldset class=\"hidden-fields-container\"><input type=\"hidden\" name=\"_wpcf7\" value=\"8836\" \/><input type=\"hidden\" name=\"_wpcf7_version\" value=\"6.2.3\" \/><input type=\"hidden\" name=\"_wpcf7_locale\" value=\"tr_TR\" \/><input type=\"hidden\" name=\"_wpcf7_unit_tag\" value=\"wpcf7-f8836-o1\" \/><input type=\"hidden\" name=\"_wpcf7_container_post\" value=\"0\" \/><input type=\"hidden\" name=\"_wpcf7_posted_data_hash\" value=\"\" \/>\n<\/fieldset>\n<div class=\"sp-form\">\n\t<div class=\"col-row\">\n\t\t<div class=\"col-quarter\">\n\t\t\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"text-340\"><input size=\"40\" maxlength=\"400\" class=\"wpcf7-form-control wpcf7-text wpcf7-validates-as-required\" autocomplete=\"name\" aria-required=\"true\" aria-invalid=\"false\" placeholder=\"Nume\" value=\"\" type=\"text\" name=\"text-340\" \/><\/span>\n\t\t\t<\/p>\n\t\t<\/div>\n\t\t<div class=\"col-quarter\">\n\t\t\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"tel-10\"><input size=\"40\" maxlength=\"400\" class=\"wpcf7-form-control wpcf7-tel wpcf7-validates-as-required wpcf7-text wpcf7-validates-as-tel\" autocomplete=\"name\" aria-required=\"true\" aria-invalid=\"false\" placeholder=\"Telefon\" value=\"\" type=\"tel\" name=\"tel-10\" \/><\/span>\n\t\t\t<\/p>\n\t\t<\/div>\n\t\t<div class=\"col-quarter\">\n\t\t\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"email-563\"><input size=\"40\" maxlength=\"400\" class=\"wpcf7-form-control wpcf7-email wpcf7-validates-as-required wpcf7-text wpcf7-validates-as-email\" autocomplete=\"name\" aria-required=\"true\" aria-invalid=\"false\" placeholder=\"E-mail\" value=\"\" type=\"email\" name=\"email-563\" \/><\/span>\n\t\t\t<\/p>\n\t\t<\/div>\n\t\t<div class=\"col-quarter\">\n\t\t\t<p><input class=\"wpcf7-form-control wpcf7-submit has-spinner\" type=\"submit\" value=\"TRIMITE\" \/>\n\t\t\t<\/p>\n\t\t<\/div>\n\t<\/div>\n<\/div><p style=\"display: none !important;\" class=\"akismet-fields-container\" data-prefix=\"_wpcf7_ak_\"><label>&#916;<textarea name=\"_wpcf7_ak_hp_textarea\" cols=\"45\" rows=\"8\" maxlength=\"100\"><\/textarea><\/label><input type=\"hidden\" id=\"ak_js_1\" name=\"_wpcf7_ak_js\" value=\"84\"\/><script>\ndocument.getElementById( \"ak_js_1\" ).setAttribute( \"value\", ( new Date() ).getTime() );\n<\/script>\n<\/p><div class=\"wpcf7-response-output\" aria-hidden=\"true\"><\/div>\n<\/form>\n<\/div>\n\n\n\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1761202747 > .col-inner {\n  margin: 0px 0px -60px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-491077400\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n\t<div id=\"text-398907627\" class=\"text\">\n\t\t\n\n<p>*V\u0103 recomand\u0103m s\u0103 completa\u021bi toate c\u00e2mpurile pentru a primi cel mai bun r\u0103spuns posibil.<\/p>\n\t\t\n<style>\n#text-398907627 {\n  font-size: 0.85rem;\n  line-height: 1.5;\n}\n@media (min-width:550px) {\n  #text-398907627 {\n    line-height: 0.75;\n  }\n}\n<\/style>\n\t<\/div>\n\t\n\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-491077400 > .col-inner {\n  margin: 0px 0px -40px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n<\/div>\n\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1734373985 > .col-inner {\n  padding: 0px 0px 0px 0px;\n  margin: 0px 0px -20px 0px;\n}\n@media (min-width:550px) {\n  #col-1734373985 > .col-inner {\n    padding: 20px 0px 0px 0px;\n    margin: 0px 0px -66px 0px;\n  }\n}\n<\/style>\n\t<\/div>\n\n\t\n\n<\/div>\n\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-627088743 > .col-inner {\n  padding: 30px 10px 0px 10px;\n  border-radius: 30px;\n}\n@media (min-width:550px) {\n  #col-627088743 > .col-inner {\n    padding: 0px 20px 0px 0px;\n  }\n}\n<\/style>\n\t<\/div>\n\n\t\n\n<\/div>\n\n\t\t<\/div>\n\n\t\t\n<style>\n#section_1764528020 {\n  padding-top: 30px;\n  padding-bottom: 30px;\n}\n<\/style>\n\t<\/section>\n\t\n<h2><span class=\"ez-toc-section\" id=\"Cum_Se_Dezvolta_Cancerul_Tiroidian_Papilar\"><\/span>Cum Se Dezvolt\u0103 Cancerul Tiroidian Papilar?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p> Cancerul tiroidian papilar se dezvolt\u0103 printr-o combina\u021bie de muta\u021bii genetice \u0219i modific\u0103ri ale c\u0103ilor de semnalizare. Una dintre cele mai importante muta\u021bii din acest proces este modificarea genei BRAF. \u00cen special, muta\u021bia BRAFV600E activeaz\u0103 continuu calea MAPK, care controleaz\u0103 cre\u0219terea celular\u0103. Ca urmare, celulele se \u00eenmul\u021besc rapid \u0219i cre\u0219te poten\u021bialul tumorii de a se r\u0103sp\u00e2ndi la \u021besuturile \u00eenconjur\u0103toare.<\/p>\n<p>O alt\u0103 muta\u021bie esen\u021bial\u0103 este reprezentat\u0103 de rearanj\u0103rile RET\/PTC. \u00cen acest caz, segmente ale genei RET se combin\u0103 cu alte gene, declan\u0219\u00e2nd cre\u0219terea necontrolat\u0103 a celulelor tiroidiene. Aceste rearanj\u0103ri sunt mai frecvente la persoanele expuse la radia\u021bii \u0219i joac\u0103 un rol important \u00een dezvoltarea cancerului.<\/p>\n<p>Al\u021bi factori implica\u021bi \u00een dezvoltarea cancerului tiroidian papilar includ:<\/p>\n<ul>\n<li>Modific\u0103ri ale c\u0103ii PI3K\/AKT: accelereaz\u0103 cre\u0219terea \u0219i progresia tumorii.<\/li>\n<li>Muta\u021bii \u00een promotorul TERT: sporesc agresivitatea tumorii, cresc\u00e2nd riscul de metastaze \u0219i recidiv\u0103.<\/li>\n<li>Modific\u0103ri epigenetice: joac\u0103 un rol \u00een reglarea modific\u0103rilor genetice.<\/li>\n<\/ul>\n<p> Factorii de mediu contribuie de asemenea la procesul de formare a cancerului. \u00cen mod special, <a href=\"https:\/\/ozgurkilickesmez.com\/ro\/ce-este-iodul-la-ce-foloseste-necesarul-zilnic-si-beneficiile-iodului\/\">deficitul de iod<\/a> sau expunerea la radia\u021bii pot accelera acest proces. Mai mult, tulbur\u0103rile de \u00eembinare alternativ\u0103 mediate de molecule precum HNRNPC, implicate \u00een metabolismul ARN, pot sus\u021bine malignitatea prin sporirea capacit\u0103\u021bii celulelor canceroase de a-\u0219i satisface nevoile energetice. Acest lucru le ofer\u0103 acestor celule o mai mare capacitate de supravie\u021buire \u0219i de r\u0103sp\u00e2ndire. <\/p>\n<h2><span class=\"ez-toc-section\" id=\"Care_Sunt_Simptomele_Cancerului_Tiroidian_Papilar\"><\/span>Care Sunt Simptomele Cancerului Tiroidian Papilar?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p> Cancerul tiroidian papilar poate fi ini\u021bial asimptomatic, dar odat\u0103 cu progresia sa, pot ap\u0103rea diverse simptome. De obicei, aceste simptome devin mai evidente pe m\u0103sur\u0103 ce tumora cre\u0219te \u0219i pot afecta via\u021ba cotidian\u0103 a pacientului. Aceste manifest\u0103ri sunt legate de modific\u0103rile din zona g\u00e2tului \u0219i de presiunea exercitat\u0103 asupra \u021besuturilor adiacente. <\/p>\n<ul>\n<li>Umfl\u0103tur\u0103 la g\u00e2t: Cel mai frecvent simptom al cancerului tiroidian papilar este un nodul nedureros, cu cre\u0219tere lent\u0103, situat \u00een partea anterioar\u0103 a g\u00e2tului. Adesea, pacientul nu observ\u0103 aceast\u0103 umfl\u0103tur\u0103, fiind descoperit\u0103 \u00een timpul unui control de rutin\u0103.<\/li>\n<li>R\u0103gu\u0219eal\u0103 sau modific\u0103ri ale vocii: Dac\u0103 tumora este situat\u0103 aproape de corzile vocale, poate cauza r\u0103gu\u0219eal\u0103 persistent\u0103 sau modific\u0103ri ale tonalit\u0103\u021bii vocii, vizibile \u00een special \u00een stadii avansate.<\/li>\n<li>Umflarea g\u00e2tului: M\u0103rirea ganglionilor limfatici poate fi cauzat\u0103 de r\u0103sp\u00e2ndirea cancerului. Aceast\u0103 umfl\u0103tur\u0103 poate fi vizibil\u0103 din exterior.<\/li>\n<li>Dificult\u0103\u021bi la \u00eenghi\u021bire sau respira\u021bie: Odat\u0103 cu cre\u0219terea tumorii, aceasta poate exercita presiune asupra esofagului sau traheei, provoc\u00e2nd dificult\u0103\u021bi la \u00eenghi\u021bire \u0219i respira\u021bie. Simptomele variaz\u0103 \u00een func\u021bie de dimensiunea tumorii.<\/li>\n<li>Durere \u00een zona g\u00e2tului sau faringelui: \u00cen unele cazuri pot ap\u0103rea dureri u\u0219oare sau severe \u00een aceste regiuni. Acestea sunt simptome mai rare, dar pot deveni mai intense \u00een timp.<\/li>\n<li>Senza\u021bie de presiune: Se poate resim\u021bi o presiune sau o senza\u021bie de str\u00e2ngere la nivelul g\u00e2tului.<\/li>\n<\/ul>\n\n\t<section class=\"section dark\" id=\"section_448042845\">\n\t\t<div class=\"section-bg fill\" >\n\t\t\t\t\t\t\t\t\t\n\t\t\t\n\n\t\t<\/div>\n\n\t\t\n\n\t\t<div class=\"section-content relative\">\n\t\t\t\r\n\r\n\t<div id=\"gap-295981414\" class=\"gap-element clearfix hide-for-medium\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-295981414 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\r\n\r\n<div class=\"row align-middle\"  id=\"row-665010112\">\r\n\r\n\n\t<div id=\"col-1613376021\" class=\"col medium-8 small-12 large-8\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\r\n\r\n\t<div id=\"text-2454304066\" class=\"text\">\n\t\t\r\n\r\n<div><strong>Contacteaz\u0103-l acum pe Prof. Dr. \u00d6zg\u00fcr K\u0131l\u0131\u00e7kesmez pentru informa\u021bii detaliate \u0219i pentru a programa o consulta\u021bie!<\/strong><\/div>\r\n\t\t\n<style>\n#text-2454304066 {\n  font-size: 1.25rem;\n  text-align: center;\n}\n@media (min-width:550px) {\n  #text-2454304066 {\n    font-size: 1.15rem;\n  }\n}\n@media (min-width:850px) {\n  #text-2454304066 {\n    font-size: 1.5rem;\n    text-align: left;\n  }\n}\n<\/style>\n\t<\/div>\n\t\r\n\r\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1613376021 > .col-inner {\n  padding: 20px 0px 0px 0px;\n  margin: 0px 0px -10px 0px;\n}\n@media (min-width:550px) {\n  #col-1613376021 > .col-inner {\n    padding: 0px 0px 0px 0px;\n  }\n}\n<\/style>\n\t<\/div>\n\n\t\r\n\n\t<div id=\"col-161194499\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner text-center\"  >\n\t\t\t\n\t\t\t\r\n\r\n<a href=\"https:\/\/api.whatsapp.com\/send\/?phone=905405032303&#038;text=Bun\u0103%2C+v\u0103+contactez+de+pe+https%3A%2F%2Fozgurkilickesmez.com%2F&#038;type=phone_number&#038;app_absent=0\" target=\"_blank\" class=\"button alert is-small box-shadow-5\" rel=\"noopener\" style=\"border-radius:10px;padding:5px 20px 5px 20px;\">\n\t\t<span>Contact prin Whatsapp<\/span>\n\t<i class=\"icon-whatsapp\" aria-hidden=\"true\"><\/i><\/a>\n\r\n\r\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-161194499 > .col-inner {\n  padding: 20px 0px 0px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\r\n\r\n<\/div>\r\n\r\n\t\t<\/div>\n\n\t\t\n<style>\n#section_448042845 {\n  padding-top: 0px;\n  padding-bottom: 0px;\n  background-color: #396cf0;\n}\n<\/style>\n\t<\/section>\n\t\r\n\t<div id=\"gap-446964985\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-446964985 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\r\n\n<h2><span class=\"ez-toc-section\" id=\"Cum_Se_Diagnostica_Cancerul_Tiroidian_Papilar\"><\/span>Cum Se Diagnostic\u0103 Cancerul Tiroidian Papilar?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p> Diagnosticul cancerului tiroidian papilar se realizeaz\u0103 \u00een mai multe etape, fiecare contribuind la confirmarea diagnosticului. Ini\u021bial, ecografia este utilizat\u0103 frecvent pentru a evalua nodulii tiroidieni. Prezen\u021ba hipoecogenit\u0103\u021bii, a marginilor neregulate \u0219i a microcalcific\u0103rilor indic\u0103 posibilitatea unui tumor maligne. De asemenea, ecografia este eficient\u0103 \u00een identificarea ganglionilor limfatici metastazici.<\/p>\n<p>Urm\u0103torul pas este biopsia prin aspira\u021bie cu ac fin (FNA), efectuat\u0103 sub ghidaj ecografic. Aceast\u0103 metod\u0103 permite analiza citologic\u0103 a e\u0219antioanelor prelevate din noduli. Sistemul Bethesda este utilizat pentru a clasifica nodulii ca benigni sau maligni.<\/p>\n<p>\u00cen cazurile \u00een care rezultatele FNA sunt neconcludente, se utilizeaz\u0103 teste moleculare. Acestea analizeaz\u0103 muta\u021bii genetice pentru a clarifica diagnosticul. Cele mai frecvente muta\u021bii \u00eent\u00e2lnite \u00een cancerul tiroidian papilar sunt BRAF V600E, muta\u021biile RAS \u0219i rearanj\u0103rile RET\/PTC, oferind dovezi solide pentru existen\u021ba unei tumori maligne.<\/p>\n<ul>\n<li>Ecografie: Prima etap\u0103 pentru evaluarea nodulilor \u0219i a ganglionilor limfatici metastazici.<\/li>\n<li>Biopsie prin aspira\u021bie cu ac fin (FNA): Standardul de aur \u00een diagnostic, cu e\u0219antioane citologice.<\/li>\n<li>Teste moleculare: Sus\u021bin diagnosticul prin identificarea muta\u021biilor genetice.<\/li>\n<\/ul>\n<p> Confirmarea final\u0103 a diagnosticului se face prin examinare histopatologic\u0103 dup\u0103 interven\u021bia chirurgical\u0103. <\/p>\n<h2><span class=\"ez-toc-section\" id=\"Cum_Se_Trateaza_Cancerul_Tiroidian_Papilar\"><\/span>Cum Se Trateaz\u0103 Cancerul Tiroidian Papilar?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p> Tratamentul cancerului tiroidian papilar include metode minim invazive precum abla\u021bia cu radiofrecven\u021b\u0103 (RFA) sau abla\u021bia cu microunde (MWA). Aceste tehnici sunt folosite \u00een special \u00een tumorile mici \u0219i localizate, fiind alternative la interven\u021bia chirurgical\u0103. RFA, realizat\u0103 sub ghidaj ecografic, distruge celulele canceroase prin \u00eenc\u0103lzire. Este o op\u021biune eficient\u0103 pentru pacien\u021bii care nu sunt candida\u021bi pentru interven\u021bie chirurgical\u0103 sau care vor s\u0103 evite riscurile operatorii.<\/p>\n<p>Principalele avantaje ale tehnologiilor MWA \u0219i RFA sunt:<\/p>\n<ul>\n<li>P\u0103streaz\u0103 glanda tiroid\u0103, reduc\u00e2nd nevoia de tratament de substitu\u021bie hormonal\u0103.<\/li>\n<li>Tehnici minim invazive, cu durat\u0103 scurt\u0103 de recuperare \u0219i durere redus\u0103 (procedura dureaz\u0103 20 minute).<\/li>\n<li>Incizii minime (1 mm), f\u0103r\u0103 cicatrici vizibile \u00een compara\u021bie cu chirurgia clasic\u0103.<\/li>\n<li>Costuri mai reduse comparativ cu interven\u021bia chirurgical\u0103.<\/li>\n<\/ul>\n<p> Eficien\u021ba RFA a fost confirmat\u0103 prin numeroase studii, demonstr\u00e2nd o reducere semnificativ\u0103 a volumului tumoral. Meta-analizele arat\u0103 c\u0103 majoritatea tumorilor tratate dispar. De\u0219i complica\u021biile sunt rare (iritarea nervilor, arsuri cutanate), aceste riscuri sunt minime atunci c\u00e2nd procedura este efectuat\u0103 de radiologi cu experien\u021b\u0103. Aceast\u0103 tehnic\u0103 este tot mai frecvent preferat\u0103 ca o op\u021biune eficient\u0103 \u00eentre chirurgie \u0219i supraveghere activ\u0103. <\/p>\n<h2><span class=\"ez-toc-section\" id=\"Care_Sunt_Factorii_de_Risc_ai_Cancerului_Tiroidian_Papilar\"><\/span>Care Sunt Factorii de Risc ai Cancerului Tiroidian Papilar?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p> Factorii de risc pentru cancerul tiroidian papilar pot fi genetici, de mediu \u0219i clinici. Printre factorii genetici, antecedentele familiale de cancer tiroidian au o importan\u021b\u0103 major\u0103. De asemenea, sindroamele genetice precum polipoza adenomatoas\u0103 familial\u0103 \u0219i sindromul Cowden cresc riscul. Muta\u021biile \u00een genele BRAF \u0219i RET\/PTC sunt puternic asociate cu cancerul tiroidian papilar. Muta\u021biile BRAF sunt mai frecvente \u00een formele agresive \u0219i indic\u0103 un prognostic mai prost.<\/p>\n<p>Expunerea la radia\u021bii, \u00een special \u00een copil\u0103rie, este un factor de mediu semnificativ. Aceasta poate rezulta din tratamente medicale sau accidente nucleare, iar dezvoltarea cancerului poate dura zeci de ani.<\/p>\n<p>V\u00e2rsta \u0219i sexul sunt, de asemenea, factori determinan\u021bi. Inciden\u021ba este de trei ori mai mare la femei, care tind s\u0103 dezvolte boala la v\u00e2rste mai tinere, \u00een timp ce la b\u0103rba\u021bi este mai frecvent\u0103 la v\u00e2rste mai \u00eenaintate.<\/p>\n<p>Aportul de iod joac\u0103 un rol important. At\u00e2t deficitul, c\u00e2t \u0219i excesul de iod pot cre\u0219te riscul de disfunc\u021bii tiroidiene \u0219i cancer tiroidian papilar. \u00cen plus, afec\u021biunile tiroidiene existente, \u00een special tiroidita Hashimoto \u0219i <a href=\"https:\/\/ozgurkilickesmez.com\/ro\/guatr\/\">gu\u0219a<\/a> nodular\u0103, pot cre\u0219te riscul dezvolt\u0103rii acestei forme de cancer.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Cand_Poate_Fi_Tratata_Cancerul_Tiroidian_Papilar\"><\/span>C\u00e2nd Poate Fi Tratat\u0103 Cancerul Tiroidian Papilar?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p> Tratamentul cancerului tiroidian papilar este planificat \u00een func\u021bie de stadiul bolii, grupa de risc \u0219i dimensiunea tumorii. La pacien\u021bii cu risc sc\u0103zut \u0219i tumori mici \u2013 \u00een special \u00een cazurile de microcarcinom papilar \u2013 se pot prefera metodele minim invazive. Aceste tehnici sunt potrivite pentru pacien\u021bii care nu doresc sau nu pot suporta interven\u021bia chirurgical\u0103. Ele permit p\u0103strarea func\u021biei tiroidiene \u0219i reduc timpul de recuperare.<\/p>\n<p>Printre metodele minim invazive se num\u0103r\u0103:<\/p>\n<ul>\n<li>Abla\u021bia cu radiofrecven\u021b\u0103 (RFA): Aplicat\u0103 pentru reducerea volumului tumorii \u00een cancere papilare cu risc sc\u0103zut.<\/li>\n<li>Abla\u021bia cu microunde (MWA): Preferat\u0103 pentru noduli mai mari, utilizeaz\u0103 energie de microunde pentru tratament.<\/li>\n<li>Abla\u021bia cu laser (LA): Utilizat\u0103 \u00een principal pentru noduli benigni, dar \u0219i \u00een unele cazuri de cancer cu risc sc\u0103zut.<\/li>\n<\/ul>\n<p> Aceste metode pot \u00eenlocui interven\u021bia chirurgical\u0103 \u00een stadiile incipiente ale cancerului tiroidian. Planul de tratament se stabile\u0219te \u00een func\u021bie de starea general\u0103 a pacientului \u0219i de preferin\u021bele acestuia. \u00cen special \u00een cazul tumorilor mici \u0219i localizate, aceste tehnici pot reprezenta o alternativ\u0103 eficient\u0103 la opera\u021bie. \u00cen compara\u021bie cu chirurgia clasic\u0103, metodele minim invazive presupun mai pu\u021bine riscuri \u0219i complica\u021bii.<\/p>\n<p>\u00cen cazurile \u00een care tumorile sunt mai mari sau cancerul are un caracter mai agresiv, chirurgia r\u0103m\u00e2ne metoda principal\u0103 de tratament. Cu toate acestea, metodele minim invazive pot fi utilizate \u00een unele situa\u021bii ca op\u021biuni complementare. <\/p>\n<h2><span class=\"ez-toc-section\" id=\"Cand_Nu_Poate_Fi_Aplicat_Tratamentul_Cancerului_Tiroidian_Papilar\"><\/span>C\u00e2nd Nu Poate Fi Aplicat Tratamentul Cancerului Tiroidian Papilar?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p> \u00cen tratamentul cancerului tiroidian papilar, abla\u021bia prin radiofrecven\u021b\u0103 (RFA) sau metode similare poate fi contraindicat\u0103 la anumi\u021bi pacien\u021bi. Inaplicabilitatea acestor metode se bazeaz\u0103 pe factori clinici \u0219i anatomici. \u00cen special localizarea, dimensiunea tumorii \u0219i stadiul de extindere a bolii sunt esen\u021biale. De exemplu, dac\u0103 tumora este situat\u0103 \u00een apropierea traheei, esofagului sau nervului laringian recurent, RFA nu este preferat\u0103 din cauza riscului crescut de leziuni nervoase sau complica\u021bii severe. Dimensiunea tumorii \u0219i gradul de invazie limiteaz\u0103 de asemenea aplicabilitatea metodelor de abla\u021bie. <\/p>\n<ul>\n<li>Apropierea de Structuri Critice: Dac\u0103 tumora este aproape de trahee, esofag sau nervi, abla\u021bia este contraindicat\u0103.<\/li>\n<li>Dimensiune \u0219i Invazie Tumoral\u0103: Abla\u021bia este de obicei indicat\u0103 pentru tumori mici (\u22642 cm). Nu se recomand\u0103 \u00een cazul tumorilor mari sau invazive.<\/li>\n<li>Metastaze Ganglionare: R\u0103sp\u00e2ndirea cancerului \u00een afara glandei tiroide sau metastazele ganglionare contraindic\u0103 abla\u021bia.<\/li>\n<li>Agresivitate Histologic\u0103: \u00cen tumorile cu variante agresive, se prefer\u0103 chirurgia sau terapia cu iod radioactiv \u00een locul abla\u021biei.<\/li>\n<\/ul>\n<p> Factori lega\u021bi de pacient, cum ar fi starea general\u0103 precar\u0103 de s\u0103n\u0103tate, comorbidit\u0103\u021bile sau contraindica\u021biile pentru anestezie, pot limita aplicarea acestor metode. Prin urmare, terapiile de abla\u021bie sunt aplicabile doar \u00een cazuri selectate, iar \u00een formele avansate sau agresive ale bolii trebuie preferate alternativele terapeutice adecvate. <\/p>\n<h2><span class=\"ez-toc-section\" id=\"Care_Este_Procesul_de_Recuperare_Dupa_Tratamentul_Cancerului_Tiroidian_Papilar\"><\/span>Care Este Procesul de Recuperare Dup\u0103 Tratamentul Cancerului Tiroidian Papilar?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p> Recuperarea dup\u0103 tratamentul cancerului tiroidian papilar este \u00een general rapid\u0103 \u0219i confortabil\u0103. Alegerea tehnicilor minim invazive, precum abla\u021bia cu microunde sau cu radiofrecven\u021b\u0103, reduce semnificativ riscul de complica\u021bii. Pacien\u021bii resimt mai pu\u021bin disconfort postoperator \u0219i \u00ee\u0219i pot relua rapid activit\u0103\u021bile cotidiene. Printre avantajele perioadei de recuperare se num\u0103r\u0103: <\/p>\n<ul>\n<li aria-level=\"1\">Pierderi minime de s\u00e2nge.<\/li>\n<li aria-level=\"1\">Reducerea duratei de spitalizare.<\/li>\n<li aria-level=\"1\">Complica\u021bii postoperatorii mai rare.<\/li>\n<li aria-level=\"1\">P\u0103strarea func\u021biei tiroidiene \u0219i sc\u0103derea necesarului de terapie hormonal\u0103.<\/li>\n<\/ul>\n<p> Aceste beneficii contribuie la o calitate mai bun\u0103 a vie\u021bii. \u00cen perioada de urm\u0103rire, examin\u0103rile imagistice regulate sunt importante pentru monitorizarea statusului tumoral, permi\u021b\u00e2nd o supraveghere atent\u0103 \u0219i interven\u021bii la timp dac\u0103 este necesar. <\/p>\n<h2><span class=\"ez-toc-section\" id=\"Cum_Poate_Fi_Prevenit_Cancerul_Tiroidian_Papilar\"><\/span>Cum Poate Fi Prevenit Cancerul Tiroidian Papilar?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p> Prevenirea cancerului tiroidian papilar implic\u0103 mai multe strategii. Primul pas este reducerea expunerii la radia\u021bii, \u00een special \u00een copil\u0103rie, \u00eentruc\u00e2t expunerea la radia\u021bii cre\u0219te semnificativ riscul de cancer. Prin urmare, investiga\u021biile imagistice inutile ar trebui evitate.<\/p>\n<p>\u00cen al doilea r\u00e2nd, aportul de iod trebuie s\u0103 fie echilibrat. At\u00e2t deficitul c\u00e2t \u0219i excesul de iod afecteaz\u0103 negativ s\u0103n\u0103tatea tiroidei. Se recomand\u0103 un aport adecvat de iod prin alimenta\u021bie.<\/p>\n<p>Evaluarea factorilor genetici este de asemenea important\u0103. Persoanele cu antecedente familiale pot beneficia de consiliere genetic\u0103. Aceast\u0103 abordare sprijin\u0103 screeningul \u00een r\u00e2ndul celor cu risc crescut.<\/p>\n<p>Modific\u0103rile stilului de via\u021b\u0103 reprezint\u0103 o alt\u0103 component\u0103 preventiv\u0103. Factori precum obezitatea, care pot fi influen\u021ba\u021bi, cresc riscul de cancer tiroidian. O alimenta\u021bie s\u0103n\u0103toas\u0103 \u0219i exerci\u021biul fizic regulat pot reduce acest risc.<\/p>\n<p>De asemenea, \u00een cazul nodulilor tiroidieni mici, se poate adopta o strategie de supraveghere activ\u0103, care vizeaz\u0103 reducerea interven\u021biilor inutile \u0219i prevenirea complica\u021biilor ulterioare. Aplicarea acestor strategii \u00een combina\u021bie poate contribui la reducerea riscului de cancer tiroidian papilar.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Intrebari_Frecvente\"><\/span>\u00centreb\u0103ri Frecvente<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>De ce este cancerul tiroidian papilar cel mai frecvent tip de cancer tiroidian?<\/p>\n<p>Cancerul tiroidian papilar (PTC) reprezint\u0103 aproximativ 80-90% din toate cazurile de cancer tiroidian, fiind astfel cea mai frecvent\u0103 form\u0103. Aceast\u0103 prevalen\u021b\u0103 crescut\u0103 se datoreaz\u0103 dezvolt\u0103rii tehnicilor de diagnostic, care permit identificarea timpurie a tumorilor mici \u0219i asimptomatice. Factori precum expunerea la radia\u021bii, obezitatea \u0219i mediul contribuie, de asemenea, la frecven\u021ba crescut\u0103. Este mai des \u00eent\u00e2lnit la femei, cu un raport femei\/b\u0103rba\u021bi de 3:1 p\u00e2n\u0103 la 4,5:1. Ace\u0219ti factori combinat fac din PTC cea mai frecvent\u0103 form\u0103 de cancer tiroidian.<\/p>\n<p>C\u00e2t de importan\u021bi sunt factorii genetici \u00een acest tip de cancer?<\/p>\n<p>Factorii genetici joac\u0103 un rol major \u00een dezvoltarea PTC. Muta\u021bia V600E \u00een gena BRAF se g\u0103se\u0219te la aproximativ 45% din cazuri \u0219i este asociat\u0103 cu forme agresive, invazie extratiroidian\u0103 \u0219i metastaze ganglionare. Rearanjamentele genei RET apar la ~10% dintre pacien\u021bi, fiind asociate cu diagnostic la v\u00e2rste mai tinere \u0219i tumori multifocale. Muta\u021biile promotorului TERT sunt prezente \u00een ~9,4% din cazuri, adesea \u00eempreun\u0103 cu BRAF sau RAS, duc\u00e2nd la expresie crescut\u0103 a TERT \u0219i prognostic mai prost. Asocieri genetice de tip SNP (de exemplu rs965513 l\u00e2ng\u0103 FOXE1 \u0219i rs944289 l\u00e2ng\u0103 NKX2-1) au fost legate de risc crescut, cu un OR \u00eentre 1,28 \u0219i 1,70.<\/p>\n<p>Ce se \u00eent\u00e2mpl\u0103 dac\u0103 acest cancer nu este tratat?<\/p>\n<p>Netratat, PTC progreseaz\u0103 lent. Rata general\u0103 de supravie\u021buire la 10 ani este de 86,34% \u00een stadiul I \u0219i 66,03% \u00een stadiul II. Totu\u0219i, 10% dintre cazuri pot deveni invazive, 5% pot face metastaze la distan\u021b\u0103 \u0219i 20-30% pot recidiva. Supravie\u021buirea scade pe m\u0103sur\u0103 ce boala avanseaz\u0103: peste 99,5% la stadiu localizat \u0219i doar 74% \u00een prezen\u021ba metastazelor. Factorii precum v\u00e2rsta, dimensiunea tumorii \u0219i variantele agresive afecteaz\u0103 negativ prognosticul.<\/p>\n<p>C\u00e2t de eficient\u0103 este terapia cu iod radioactiv dup\u0103 interven\u021bia chirurgical\u0103?<\/p>\n<p>Eficien\u021ba terapiei cu iod radioactiv (RAI) depinde de factorii de risc. La pacien\u021bii cu risc sc\u0103zut (de exemplu MACIS <7 sau metastaze minime ganglionare), RAI nu aduce \u00eembun\u0103t\u0103\u021biri semnificative \u00een supravie\u021buirea specific\u0103. La pacien\u021bii cu risc crescut (v\u00e2rst\u0103 >55 ani, >5 ganglioni afecta\u021bi sau caracteristici tumorale agresive), RAI reduce recuren\u021bele \u0219i cre\u0219te supravie\u021buirea. De exemplu, la pacien\u021bi N1b peste 55 ani, RAI a redus mortalitatea cu 52%. Totu\u0219i, dozele mari pot cre\u0219te riscul de efecte adverse, deci decizia de a aplica RAI trebuie individualizat\u0103.<\/p>\n<p>De ce este prognosticul cancerului tiroidian papilar, de obicei, favorabil?<\/p>\n<p>PTC are \u00een general un prognostic foarte bun datorit\u0103 cre\u0219terii lente, r\u0103spunsului excelent la chirurgie \u0219i RAI, \u0219i detect\u0103rii precoce. Rata de supravie\u021buire la 5 ani este de >99% \u00een cazurile localizate, 99% \u00een cele regionale \u0219i 74% \u00een metastaze la distan\u021b\u0103. Totu\u0219i, factori precum v\u00e2rsta, dimensiunea tumorii, invazia extratiroidian\u0103 \u0219i variantele histologice pot influen\u021ba prognosticul individual.<\/p>\n<p>\u00cen ce cazuri este abla\u021bia adecvat\u0103?<\/p>\n<p>Tehnicile de abla\u021bie sunt potrivite pentru pacien\u021bii cu carcinom papilar tiroidian micro (PTMC) cu risc sc\u0103zut care nu sunt eligibili pentru chirurgie sau doresc o abordare minim invaziv\u0103. Studiile au ar\u0103tat rate de dispari\u021bie tumoral\u0103 \u00eentre 79-100% \u0219i rate de complica\u021bii \u00eentre 0,6-3,2% pentru RFA. Progresia bolii, la 10 ani, a fost observat\u0103 \u00eentre 1,5-6,1%, confirm\u00e2nd eficien\u021ba \u0219i siguran\u021ba acestei metode.<\/p>\n<p>Se pot aplica tehnicile de abla\u021bie \u00een cazul recidivei cancerului tiroidian papilar dup\u0103 interven\u021bia chirurgical\u0103?<\/p>\n<p>Da, tehnicile de abla\u021bie pot fi utilizate \u00een tratamentul cancerului tiroidian papilar (PTC) recidivat dup\u0103 interven\u021bia chirurgical\u0103. Studiile arat\u0103 c\u0103 abla\u021bia cu radiofrecven\u021b\u0103 a oferit rate de vindecare complet\u0103 de 79% \u00een cazul microcarcinomului papilar cu risc sc\u0103zut \u0219i p\u00e2n\u0103 la 91,3% \u00een cazurile de recidiv\u0103 local\u0103 a PTC. De asemenea, tratamentul cu iod radioactiv a demonstrat o eficien\u021b\u0103 variabil\u0103, cu rate de succes \u00eentre 51% \u0219i 94% la pacien\u021bii cu recidive PTC de risc mediu \u0219i \u00eenalt. S-a observat c\u0103 dozele mici de iod radioactiv pot ob\u021bine rate ridicate de vindecare, men\u021bin\u00e2nd \u00een acela\u0219i timp un risc sc\u0103zut de recidiv\u0103, ceea ce le face o op\u021biune eficient\u0103 \u00een anumite cazuri de recuren\u021b\u0103.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cancerul tiroidian papilar este cel mai frecvent tip de cancer al tiroidei. Are o evolu\u021bie lent\u0103 \u0219i se poate r\u0103sp\u00e2ndi la ganglionii limfatici. \u00cen stadii incipiente, rata de supravie\u021buire este ridicat\u0103 cu tratament chirurgical \u0219i iod radioactiv. Printre factorii de risc ai cancerului tiroidian papilar se num\u0103r\u0103 expunerea la radia\u021bii, muta\u021biile genetice \u0219i antecedentele familiale. [&#8230;]\n","protected":false},"author":2,"featured_media":13560,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-13561","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/ozgurkilickesmez.com\/ro\/wp-json\/wp\/v2\/posts\/13561","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ozgurkilickesmez.com\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ozgurkilickesmez.com\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ozgurkilickesmez.com\/ro\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ozgurkilickesmez.com\/ro\/wp-json\/wp\/v2\/comments?post=13561"}],"version-history":[{"count":2,"href":"https:\/\/ozgurkilickesmez.com\/ro\/wp-json\/wp\/v2\/posts\/13561\/revisions"}],"predecessor-version":[{"id":13670,"href":"https:\/\/ozgurkilickesmez.com\/ro\/wp-json\/wp\/v2\/posts\/13561\/revisions\/13670"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ozgurkilickesmez.com\/ro\/wp-json\/wp\/v2\/media\/13560"}],"wp:attachment":[{"href":"https:\/\/ozgurkilickesmez.com\/ro\/wp-json\/wp\/v2\/media?parent=13561"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ozgurkilickesmez.com\/ro\/wp-json\/wp\/v2\/categories?post=13561"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ozgurkilickesmez.com\/ro\/wp-json\/wp\/v2\/tags?post=13561"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}